FTXH Quote, Financials, Valuation and Earnings

iShares US Healthcare Providers ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.

First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than iShares US Healthcare Providers ETF.

First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, which suggesting that the stock is 34.157% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.516%.

First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. iShares US Healthcare Providers ETF offers a yield of 0.85% to investors and pays a quarterly dividend of $0.10 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.

First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco Pharmaceuticals ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.

First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than Invesco Pharmaceuticals ETF.

First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, which suggesting that the stock is 34.157% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.580, suggesting its less volatile than the S&P 500 by 42.037%.

First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. Invesco Pharmaceuticals ETF offers a yield of 0.97% to investors and pays a quarterly dividend of $0.22 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.

First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.

First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.

First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, which suggesting that the stock is 34.157% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, suggesting its less volatile than the S&P 500 by 13.707%.

First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.7% to investors and pays a quarterly dividend of $0.06 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.

First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.

SPDR S&P Health Care Services ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat SPDR S&P Health Care Services ETF's return on equity of --.

First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than SPDR S&P Health Care Services ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than SPDR S&P Health Care Services ETF.

First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, which suggesting that the stock is 34.157% less volatile than S&P 500. In comparison SPDR S&P Health Care Services ETF has a beta of 1.019, suggesting its more volatile than the S&P 500 by 1.88%.

First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. SPDR S&P Health Care Services ETF offers a yield of 0.37% to investors and pays a quarterly dividend of $0.08 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Services ETF pays out -- of its earnings as a dividend.

First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Services ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than SPDR S&P Health Care Services ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for SPDR S&P Health Care Services ETF. Usually stocks with elevated PS ratios are considered overvalued.